Corcept Therapeutics Incorporated
CORTBiotechnology
$81.12−5.62%As of Oct 30vs prior close
- Market cap
- $8.8B
- P/E (TTM)
- 158.9×
- From 52W high
- −34.35%
- EPS (LTM)
- $0.42
- Revenue (LTM)
- $830.8M
- Net margin
- 6.64%
Nomior Score
65
Steady ProfileSpeculativeTop 17% of the scored universe
Growth50
Quality79
Value50
Momentum67
Resilience51
Growth
+28.21%revenue a year over 9 fiscal years
FY16 $81.3MLTM $830.8M
Connections
Revenue to profitQ2 FY26
17% of revenue became net profit, down 1 pt on a year.
Who owns it
1fund